AzTrials
AzTrials

Hallux ValgusNCT04145882

Efficacy of Additional Osteotomies to Correct Hallux Valgus

A study testing additional osteotomies in people with Hallux Valgus, run by Elsan at 4 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Deviation of the big toe in valgus at the level of the first metatarsophalangeal joint is called Hallux Valgus. In case of significant pain especially due to a conflict with the shoes, surgery could be indicated. Angle between the first metatarsal (M1) and the first phalangeal (P1) is named Hallux Valgus Angle (HVA). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hallux Valgus
What is being tested?
additional osteotomies
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
515 participants
Where
4 sitesFrance
Study dates
11 Sep 2019to 11 Sep 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient older than 18 years.
  • Informed consent

Who cannot join

  • Associated lesser metatarsals surgery.
  • Associated surgery on midfoot, hindfoot or ankle.
  • Neurologic diseases (Charcot Marie Tooth disease, poliomyelitis, compartment syndrome sequelae)
  • Clinical or X-ray degenerative signs (Hallux rigidus) or irreducible deformations (MTP1 arthrodesis indications).
  • Patient who declined the study.

Trial locations and contacts

4 sites in 1 country.

France4 sites
  • Clinique Lille sud

    Lesquin, 59810

  • Clinique du Parc Lyon

    Lyon, 69006

  • Clinique Mégival

    Saint-Aubin-sur-Scie, 76550

  • Clinique de l'Union

    Saint-Jean, 31240

Other trials in France

About this study

Official title: Is it Better to Add Supination Osteotomy, Varisation Osteotomy, or Both to Distal Chevron as Part of Hallux Valgus Management : a Prospective Randomized Trial

Deviation of the big toe in valgus at the level of the first metatarsophalangeal joint is called Hallux Valgus. In case of significant pain especially due to a conflict with the shoes, surgery could be indicated. Angle between the first metatarsal (M1) and the first phalangeal (P1) is named Hallux Valgus Angle (HVA). Angle between M1 and the second metatarsal (M2) is named InterMetatarsal Angle (IMA). Angle between M1 distal articular surface and M1 shaft axis in a frontal plane is named Distal Metatarsal Articular Angle (DMAA).

Insufficient surgical correction is a risk factor of recurrence (HVA>20° after surgery). According to Okuda et al in a 67 patients group treated by proximal osteotomies correction, postoperative risk factors of recurrence at 33 month of follow-up are : HVA>40° before the surgery and HVA>15° with an IMA>10° 10 weeks (3-24) after the surgery.

Read more

Currently, one of the most common used procedure is a translated (laterally) distal chevron associated with a release of the metatarso-sesamoid suspensory ligament and a Akin procedure on P1. Nevertheless this procedure does not correct deformation in all plans. HVA and IMA are corrected but DMAA and M1 pronation angle are not.

Surgeons can add three different osteotomies in this type of chevron. In the dorsal saw cut a varisation wedge osteotomy is possible , in the plantar saw cut a supination wedge osteotomy is possible, and both are possible. No studies have tried to assess these three possibilities.

The investigators hypothesize that the addition of a varisation and/or a supination wedge osteotomies in a distal chevron decrease risk factors of recurrence at six months of follow-up

Conditions
Hallux Valgus
Being tested
additional osteotomies
Medical subject headings
Hallux Valgus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • additional osteotomiesProcedure or surgery

    varisation osteotomy, supination osteotomy or both

Study groups in NCT04145882
Study groupRoleWhat they receive
No additional osteotomyActive comparatorNot described
Receives: Procedure: additional osteotomies
varisation osteotomy additionExperimentalNot described
Receives: Procedure: additional osteotomies
supination osteotomy additionExperimentalNot described
Receives: Procedure: additional osteotomies
both (varisation + supination) osteotomies addition.ExperimentalNot described
Receives: Procedure: additional osteotomies

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of patients having both Hallux Valgus Angle >15° and InterMetatarsal Angle >10°

    on weight bearing X-Rays

    Measured: 6 months

Secondary outcomes (5)
  1. Recurrence of hallux valgus (HVA>20°).

    Measured: 5 years

  2. American Orthopedic Foot and Ankle Forefoot Score (AOFAS)

    Mini 0 (Worse) - Maxi 100 (Better)

    Measured: 6 months

  3. American Orthopedic Foot and Ankle Forefoot Score (AOFAS)

    Mini 0 (Worse) - Maxi 100 (Better)

    Measured: 5 years

  4. Patient satisfaction (Likert scale)

    very satisfied/satisfied/fairly satisfied/no satisfied

    Measured: 6 months

  5. Patient satisfaction (Likert scale)

    very satisfied/satisfied/fairly satisfied/no satisfied

    Measured: 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2019
  2. Study start11 Sep 2019
  3. Primary completion29 Jul 2021
  4. Study completion11 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
515 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04145882
Sponsor's protocol ID
CPL-2019-HV
Status last verified
Feb 2024
First submitted
29 Oct 2019
Last updated
29 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing additional osteotomies in people with Hallux Valgus, run by Elsan at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of patients having both Hallux Valgus Angle >15° and InterMetatarsal Angle >10° (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in